NOT FOR DISTRIBUTION IN THE UNITED STATES, UNITED KINGDOM, THE EUROPEAN ECONOMIC AREA OR AUSTRALIA
Rapid Nutrition PLC
(“Rapid Nutrition” or “the Company”)
Rapid Nutrition Plc (RAP:SWX), a natural healthcare company focused on the research and development, manufacturing and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements and a range of life science products announces a trading update for the six months ended 31 December, 2018
The company generated revenue of £0.436m (AUD$781,000) in the period under review. The modest decline in the first six months was largely due to product regulatory challenges in Sri Lanka, which have now been addressed. The second half of the year has begun strongly with excellent progress being made across the business in support of the eventual rollout in Sri Lanka, the launch of GNC into the Australia market as well as the launch of its flagship brand SystemLS through GNC Stores in the US. Detailed planning is being finalised with retailer opening orders expected this quarter. The Company’s new health food store in Sydney, NSW Australia has performed very well since its inception mid last year. The health food store continues to deliver strong revenue’s and provides the Company with a well established platform to test new product lines and obtain consumer feedback before investing in larger production runs.
The second half of the year is anticipated to be stronger, given the phasing of its wider distribution network in the US & Australia. We remain confident that that this will be a year of substantial growth across the business.
As outlined at our Annual General Meeting, the Company continues the process of exploring the possibility of a dual listing on a suitable exchange in order to support future growth and enhanced shareholder value. The Company will inform the market once successfully concluded.
For more information, please visit http://rnplc.com
or contact Investor Relations: email@example.com
About Rapid Nutrition
Rapid is a natural healthcare company focused on the research and development, manufacturing and distribution of weight-loss and diet management products, sports nutrition products, vitamins and dietary supplements and a range of life science products. The Company has registered products in and or exported its products to Australia, Asia, India, Europe, Middle East, Africa and the US.
Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. This media information is not being issued in countries where the public dissemination of the information contained herein may be restricted or prohibited by law. In particular, this media information is not being issue in the United States of America and should not be distributed to U.S. persons or publications with a general circulation in the United States. Any non-compliance with such restrictions may result in an infringement of U.S. Securities Laws. In particular, the securities of Rapid Nutrition PLC have not been registered under the U.S. Securities laws and may not be offered, sold or delivered within the United States or to U.S. persons absent the registration under or an applicable exemption from the registration requirements of the U.S. Securities laws. This information is for distribution in the United Kingdom only to: persons who (i) are outside the United Kingdom; (ii) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (Order); (iii) are persons falling within Article 48(2) of the Order (certified high net worth individuals); (iv) are persons falling within Article 49(2) of the Order (high net worth companies, unincorporated associations, etc.); (v) are persons falling within article 50(1) of the Order (sophisticated investors); (vi) are persons falling within article 50A(1) of the Order (self-certified sophisticated investors); (vii) are persons falling within article 51 of the Order (associations of high net worth or sophisticated investors); or (viii) are persons to whom it may otherwise lawfully be communicated (all such persons together being Relevant Persons). This media information is only available to Relevant Persons and persons other than Relevant Persons must not act or rely on it. This media information may not be provided in Australia other than to select investors ("Exempt Investors") who are able to demonstrate that they (a) fall within one or more of the categories of investors under section 708 of the Australian Corporations Act to whom an offer may be made without disclosure under Part 6D.2 of the Australian Corporations Act and (b) are "wholesale clients" for the purpose of section 761G of the Australian Corporations Act.